On June 20 th, TimesSquare Capital Management, an equity investment management company, released its 'US Small Cap Growth Strategy' first-quarter 2024 investor letter. TimesSquare Capital US Small Cap Growth Strategy highlighted stocks like Krystal Biotech, Inc., in the first quarter 2024 investor letter. Krystal Biotech, Inc. is a commercial-stage biotechnology company that develops genetic medicines for patients with rare diseases. The one-month return of Krystal Biotech was 5.15%, and its shares gained 43.27% of their value over the last 52 weeks. On June 20, 2024, the stock closed at $171.21 per share with a market capitalization of $4.889 billion.